Carcinoid Tumor Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials

Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Patients With Inoperable, Somatostatin Receptor Positive, Midgut Carcinoid Tumors, Progressive Under Somatostatin Analogue Therapy
Condition:   Midgut Carcinoid TumorIntervention:   Drug: 177Lu-DOTA0-Tyr3-OctreotateSponsor:   Advanced Accelerator ApplicationsAvailable - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2016 Category: Research Source Type: clinical trials

Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
Conditions:   Carcinoid Tumors;   Pancreatic NETIntervention:   Drug: IbrutinibSponsors:   H. Lee Moffitt Cancer Center and Research Institute;   PharmacyclicsRecruiting - verified October 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2015 Category: Research Source Type: clinical trials